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Abstract Treatment of HL60 cells with phorbol 12-myristate
13-acetate (PMA) results in growth arrest and differentiation
towards the macrophage lineage. PMA-induced changes are
easily monitored by morphological changes while cells in
suspension start adhering onto substrate. PMA induces rapid
activation of the extracellular signal-regulated kinases (ERKs).
Activation of the ERK pathway is essential to PMA-induced
differentiation of HL60 cells. PMA also induces the expression
of the cyclin-dependent kinase inhibitors p21WAF and p27kip1,
which is modulated by the use of an inhibitor of the ERK
cascade. This implies that a link exists between ERK activation
and p21WAF and p27kip1 induction in the process of terminal
differentiation.
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1. Introduction
Activation of mitogen-activated protein kinase (MAPK)
family members is involved in a wide range of cellular func-
tions. MAPK activity is elevated in response to proliferative
factors [1,2], as well as in response to di¡erentiating factors
such as nerve growth factor (NGF) [3]. In PC12 cells, pro-
longed activation of extracellular signal-regulated kinase
(ERK)-1 and -2 correlates with the NGF-induced di¡erentia-
tion [4]. NGF suppresses the activity of cyclin-dependent ki-
nases (CDKs) in several cell types and this inhibition of CDK
activity appears to be critical in the ability of NGF to induce
di¡erentiation [5,6]. The cell cycle inhibitors p21 (WAF) and
p27 (kip1) play a critical role in the control of the cell cycle by
interacting with multiple cellular targets. p21WAF has been
implicated in mediating growth arrest in response to a variety
of conditions including terminal di¡erentiation [7]. Induction
of p21WAF in response to DNA damage occurs primarily
through a transcriptional mechanism that requires interaction
of tumor suppressor protein p53 with a p53 binding site in the
p21WAF promoter [8]. However, induction of p21WAF in other
situations, such as during cellular di¡erentiation, does not
appear to require p53 [9,10]. The mechanism that regulates
p21WAF expression in these p53-independent circumstances is
not clear.
In this study, we have addressed the role of MAPK signal-
ing pathway in regulating p21WAF and p27kip1 expression, and
their involvement in phorbol 12-myristate 13-acetate (PMA)-
induced terminal di¡erentiation of HL60 cells. Data are pre-
sented that directly link activation of the MAPK pathway to
the induction of p21WAF and p27kip1 and cellular di¡erentia-
tion in response to PMA.
2. Materials and methods
Reagents and chemicals were obtained from Sigma Chemical Co.,
St. Louis, MO, USA, unless otherwise indicated.
2.1. Cell culture and induction of di¡erentiation
HL60 promyelocytic leukemia cells were obtained form the Amer-
ican Type Culture Collection (Manassas, VA, USA) and cultured in
RPMI 1640 medium (Gibco BRL, Grand Island, NY, USA) supple-
mented with 20% heat-inactivated fetal bovine serum (FBS) (Gibco
BRL). For MAPK assay, cells in logarithmic growth were serum-
starved in RPMI medium containing 0.5% FBS for 24 h. To induce
di¡erentiation, the cells in logarithmic growth were seeded at 2U105/
ml and treated with 25 nmol/l PMA dissolved in dimethyl sulfoxide
(DMSO) (¢nal concentration of DMSO in culture medium was
0.02%). Control cultures were treated similarly with the solvent
DMSO. In this condition, the initial adherence of the cells to the
bottom of the plastic plate was seen at 24 h. To test the role of
MAPK activation in di¡erentiation, HL60 cells were pre-incubated
for 30 min with 50 WM MAPK kinase (MEK) inhibitor PD098059
(Calbiochem, San Diego, CA, USA).
2.2. Preparation of cell extracts
Cells were washed with ice cold phosphate-bu¡ered saline (PBS)
and lysed in lysis bu¡er (20 mM HEPES, pH 7.5, 150 mM NaCl,
1 mM EGTA, 1.5 mM MgCl2, 10% glycerol, 1% Triton X-100, 1 mM
PMSF, 1 Wg/ml of aprotinin, 1 Wg/ml of leupeptin, 50 mM NaF, 2 mM
sodium orthovanadate and 10 mM sodium pyrophosphate) for 30 min
on ice. The lysates were then centrifuged at 14 000Ug for 10 min and
the supernatant was either used or stored at 380‡C.
2.3. Antibodies
For Western blotting analysis, we used the following antibodies:
anti-active ERK and anti-active p38 antibodies were from Promega,
Madison, WI, USA. The p21WAF (C-19) polyclonal antibody and
ERK-2 (C-14) polyclonal antibody were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA) and p27kip1 monoclonal anti-
body from Transduction Laboratories (Lexington, KY, USA). P38
polyclonal antibody was obtained from New England Biolabs, Bev-
erly, MA, USA.
2.4. Immunoblotting
Equal amounts of protein (40^60 Wg) from HL60 cell extracts were
separated by polyacrylamide gel electrophoresis, and then transferred
to nitrocellulose. The membrane was blocked for 1 h with 5% BSA in
Tris-bu¡ered saline (TBS), pH 7.8, and then incubated with antibodies
overnight at 4‡C. The membrane was washed with TBS containing
0.1% Tween 20. Immunoreactive proteins were detected by using
horseradish peroxidase-conjugated secondary antibody (Amersham,
Arlington Height, IL, USA) and an enhanced chemiluminescence de-
tection system (Amersham).
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2.5. Assay of cellular proliferation
Cells were seeded at 5U104/ml in 60U15 mm dishes and grown for
4 days in normal growth medium or medium supplemented as de-
scribed. Cells were counted every day microscopically using a hemo-
cytometer. All experiments were counted in triplicate.
2.6. Adhesion assay
HL60 cells were seeded at 5U104/ml in normal growth medium or
medium supplemented as described. After 48 h, medium was removed.
Residual non-adherent cells were removed by washing with 3 ml of
PBS twice. Adherent cells were ¢xed in 3% paraformaldehyde in PBS
for 10 min at room temperature and stained with 0.5% crystal violet
in 20% methanol for 30 min. The stain was eluted with 0.1 M sodium
citrate, pH 4.2, in 50% ethanol and the eluate optical density mea-
sured spectrophotometrically at 550 nm.
3. Results
Treatment of HL60 cells with PMA induces functional and
morphological changes that are characteristic of terminally
di¡erentiated macrophages. To understand the early events
that lead to PMA-induced macrophage di¡erentiation in
HL60 cells, we studied the activation of three major pathways
involving MAPK family members ERK/MAPK, JNK/SAPK
and p38 by analyzing their phosphorylation state using phos-
phospeci¢c antibodies. A time-course analysis of endogenous
phosphorylated ERKs shows that PMA induces a rapid acti-
vation of ERK-1 and -2 within 5 min of PMA treatment and
then this activation goes down at 1 h (Fig. 1A). After strip-
ping of the membrane, incubation with anti-ERK-2 antibody
shows that equal amounts of ERK-2 are present in each lane.
Under similar conditions, the phosphorylation state of JNK
and p38 remained unchanged (data not shown).
To test whether or not PMA-induced activation of ERK-2
is due to MEK, we used a speci¢c MEK inhibitor, PD098059.
As shown in Fig. 1B, 50 WM PD098059 completely blocked
ERK phosphorylation, indicating that this activation is
MEK-dependent. PD098059 also inhibits the basal level of
phosphorylation of ERK in control cells. The lower panel
of Fig. 1B shows that equal amounts of ERK-2 are present
in each lane.
To investigate whether or not the ERK pathway plays any
role in the process of PMA-induced morphological changes
and di¡erentiation, we used the same MEK inhibitor. Pre-
incubation with PD098059 in the culture medium before the
addition of PMA completely blocked the morphological
changes associated with di¡erentiation (data not shown). To
substantiate this observation, an adhesion assay with crystal
violet showed that the eluate obtained from PMA-treated cells
had increased optical density (Fig. 2A), indicating cell adhe-
sion to the dish. In contrast, the eluate obtained from cells
pretreated with PD098059 and then treated with PMA had an
optical density close to the control cells, indicating that no
adherent cells were present (Fig. 2A). In addition, we found
that PMA treatment resulted in growth inhibition of HL60
cells that was evident at 48 h (Fig. 2B). To test whether mod-
ulation of MAPK activity is involved in the growth arrest,
HL60 cells were incubated with PD098059. PD098059 itself
inhibited the serum-dependent growth rate of control cells,
indicating that MAPK activation is necessary for normal
growth rate of HL60 cells.
During the process of terminal di¡erentiation induced by
PMA, HL60 cells appear to completely leave the cell cycle. To
investigate the possible mechanism of cell cycle arrest, we
Fig. 1. ERK activation in HL60 cells exposed to PMA. (A) Time-
dependent activation of ERK. After serum starvation, cells were ex-
posed to PMA for the indicated times. Lysates were analyzed by
Western blot using either anti-active ERK antibody (upper panel)
or anti-total ERK-2 antibody (lower panel). (B) Lysates from HL60
cells were prepared 15 min after exposure to PMA or vehicle (C).
Cells were pre-incubated with PD098059 (PD) where shown. West-
ern blot analysis was carried out by using either anti-active ERK
antibody (upper panel) or anti-total ERK-2 antibody (lower panel).
Anti-total ERK-2 antibody cross-reacts with ERK-1.
Fig. 2. (A) Adhesion assay of HL60 cells in the presence or absence
of PMA plus or minus PD098059 (PD). Crystal violet eluate optical
density at 586 nm was measured as described in Section 2. (B)
Growth curve of HL60 cells in the presence or absence of PMA
plus or minus PD098059 (PD). Cells were seeded and counted as
described in Section 2.
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studied the expression levels of p21WAF and p27kip1 that both
bind to and inactivate a variety of cyclin/CDK complexes and
thereby regulate the cell cycle. Exponentially growing HL60
cells express no detectable amount of p21WAF (Fig. 3A) but
have detectable levels of p27kip1 (Fig. 3B). Induction of
p21WAF and an increased expression of p27kip1 are detected
after 24 h of PMA treatment. This correlates well with the
time when these cells have a lower growth rate and start to
show the changes in adherence behavior. The high levels of
expression of both the CDK inhibitors are sustained up to 48
h of PMA treatment (data not shown). To test whether or not
the ERK pathway is also involved in the regulation of p21WAF
and p27kip1, cells were exposed to PD098059 prior to the
addition of PMA. It was observed that PD098059 completely
blocked the induction of both p21WAF (Fig. 3A) and p27kip1
(Fig. 3B). This result clearly shows that the ERK pathway is
involved in PMA-induced p21WAF and p27kip1 expression in
HL60 cells.
4. Discussion
Our data provide evidence that PMA-induced activation of
ERK in HL60 cells leads to growth arrest and terminal di¡er-
entiation. The MEK inhibitor PD098059 blocks this e¡ect.
PMA also induces p21WAF and p27kip1, which correlates well
with morphological changes of the cells and growth arrest.
HL60 cells lack p53 that is one of the activators of p21WAF
transcription. Our data suggest that increased ERK activity
leads to the induction of both p21WAF and p27kip1. In fact,
PD98059 blocks both ERK activation and p21WAF and
p27kip1 induction. At the same time, PD98059 also blocks
the morphological changes induced by PMA. This clearly in-
dicates the involvement of the ERK pathway in p21WAF and
p27kip1 induction that may lead to growth arrest and di¡er-
entiation.
Although a role of the ERK pathway in growth arrest or
cellular di¡erentiation is not unprecedented [3,11,12], our re-
sults are the ¢rst of its kind that establish a link between ERK
activation and p21WAF and p27kip1 induction in the process of
cellular di¡erentiation. The mechanism by which PMA-in-
duced activation of ERK leads to induction of p21WAF and
p27kip1 and terminal di¡erentiation in HL60 cells is not clear.
A recent report suggests that induction of p21WAF in response
to growth factor stimulation is mediated by activation of
ERK [13]. It is possible that ERK-dependent p21WAF induc-
tion occurs both in response to growth factor stimulation and
in a di¡erentiating condition. Therefore, a p53-independent
pathway exists that involves ERK and that can induce
p21WAF under appropriate stimulus. PMA could stimulate
this pathway to induce cell cycle arrest and di¡erentiation in
HL60 cells. Further knowledge of the mechanisms contrib-
uting to control p21WAF expression could improve our under-
standing of how mitogenic factors and di¡erentiating agents
e¡ect the target cells.
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Fig. 3. PMA-induced expression of p21WAF and p27kip1. Lysates
were obtained from HL60 cells treated for 24 h with either DMSO
(C) or PMA, in the presence or absence of PD098059 (PD). (A)
Western blot analysis by using anti-p21WAF antibody. (B) Western
blot analysis by using anti-p27kip1 antibody.
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